$EKSO
EKSO BIONICS HOLDINGS, INC.

2024 Q4 Form 10-Q Financial Statement

#000143774924032291 Filed on October 28, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $4.129M
YoY Change -10.38%
Cost Of Revenue $1.920M
YoY Change -10.74%
Gross Profit $2.209M
YoY Change -10.06%
Gross Profit Margin 53.5%
Selling, General & Admin $4.071M
YoY Change -3.71%
% of Gross Profit 184.29%
Research & Development $777.0K
YoY Change -32.96%
% of Gross Profit 35.17%
Depreciation & Amortization $407.0K
YoY Change 19.71%
% of Gross Profit 18.42%
Operating Expenses $4.848M
YoY Change -10.01%
Operating Profit -$2.639M
YoY Change -9.96%
Interest Expense $555.0K
YoY Change 767.19%
% of Operating Profit
Other Income/Expense, Net $567.0K
YoY Change -230.65%
Pretax Income -$2.072M
YoY Change -38.52%
Income Tax
% Of Pretax Income
Net Earnings -$2.072M
YoY Change -38.42%
Net Earnings / Revenue -50.18%
Basic Earnings Per Share -$0.10
Diluted Earnings Per Share -$0.10
COMMON SHARES
Basic Shares Outstanding 22.00M 18.44M
Diluted Shares Outstanding 20.31M

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.292M
YoY Change -16.58%
Cash & Equivalents $8.292M
Short-Term Investments
Other Short-Term Assets $779.0K
YoY Change -27.2%
Inventory $5.031M
Prepaid Expenses
Receivables $6.964M
Other Receivables $0.00
Total Short-Term Assets $21.07M
YoY Change -5.8%
LONG-TERM ASSETS
Property, Plant & Equipment $1.628M
YoY Change -21.96%
Goodwill $431.0K
YoY Change 0.0%
Intangibles $4.662M
YoY Change -6.23%
Long-Term Investments
YoY Change
Other Assets $531.0K
YoY Change 90.32%
Total Long-Term Assets $8.143M
YoY Change -7.69%
TOTAL ASSETS
Total Short-Term Assets $21.07M
Total Long-Term Assets $8.143M
Total Assets $29.21M
YoY Change -6.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.808M
YoY Change -27.74%
Accrued Expenses $1.975M
YoY Change -5.77%
Deferred Revenue $2.039M
YoY Change 24.71%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $1.250M
YoY Change 0.0%
Total Short-Term Liabilities $7.506M
YoY Change -4.19%
LONG-TERM LIABILITIES
Long-Term Debt $4.106M
YoY Change -19.01%
Other Long-Term Liabilities $165.0K
YoY Change 68.37%
Total Long-Term Liabilities $165.0K
YoY Change 68.37%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.506M
Total Long-Term Liabilities $165.0K
Total Liabilities $14.34M
YoY Change -9.96%
SHAREHOLDERS EQUITY
Retained Earnings -$247.1M
YoY Change 4.72%
Common Stock $22.00K
YoY Change 57.14%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $14.87M
YoY Change
Total Liabilities & Shareholders Equity $29.21M
YoY Change -6.33%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$2.072M
YoY Change -38.42%
Depreciation, Depletion And Amortization $407.0K
YoY Change 19.71%
Cash From Operating Activities -$2.277M
YoY Change -32.03%
INVESTING ACTIVITIES
Capital Expenditures $8.000K
YoY Change -20.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$8.000K
YoY Change -20.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.691M
YoY Change
NET CHANGE
Cash From Operating Activities -2.277M
Cash From Investing Activities -8.000K
Cash From Financing Activities 4.691M
Net Change In Cash 2.406M
YoY Change -171.61%
FREE CASH FLOW
Cash From Operating Activities -$2.277M
Capital Expenditures $8.000K
Free Cash Flow -$2.285M
YoY Change -31.99%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Registrant Name
EntityRegistrantName
EKSO BIONICS HOLDINGS, INC.
dei Entity Central Index Key
EntityCentralIndexKey
0001549084
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
29000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
79000 usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
141429000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
141429000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21998000
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21998000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14848000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14848000
CY2024Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2024Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2024Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
146000 usd
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
141429000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21998000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14848000
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2024Q3 ekso Number Of License Agreements
NumberOfLicenseAgreements
2 pure
CY2024Q3 ekso Number Of License Agreements
NumberOfLicenseAgreements
2 pure
us-gaap Longterm Purchase Commitment Period
LongtermPurchaseCommitmentPeriod
P1Y
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 pure
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37854
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
99-0367049
dei Entity Address Address Line1
EntityAddressAddressLine1
101 Glacier Point, Suite A
dei Entity Address City Or Town
EntityAddressCityOrTown
San Rafael
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94901
dei City Area Code
CityAreaCode
510
dei Local Phone Number
LocalPhoneNumber
984-1761
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
EKSO
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
21998369
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8292000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8638000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6964000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5645000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
5031000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
5050000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
779000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
875000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
21066000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
20208000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1628000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2018000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
891000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
977000 usd
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4662000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4892000 usd
CY2024Q3 us-gaap Goodwill
Goodwill
431000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
431000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
531000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
392000 usd
CY2024Q3 us-gaap Assets
Assets
29209000 usd
CY2023Q4 us-gaap Assets
Assets
28918000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1808000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1847000 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1975000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2664000 usd
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2039000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1993000 usd
CY2024Q3 us-gaap Notes Payable Current
NotesPayableCurrent
1250000 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
1250000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
434000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
363000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
7506000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8117000 usd
CY2024Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1971000 usd
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2169000 usd
CY2024Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
4106000 usd
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
4832000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
556000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
723000 usd
CY2024Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
35000 usd
CY2023Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
366000 usd
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
165000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
105000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
14339000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
16312000 usd
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
22000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
15000 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
261898000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
251580000 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
12000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
156000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-247062000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-239145000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
14870000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
12606000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
29209000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
28918000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4129000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4607000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
12835000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
13432000 usd
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1920000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2151000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6038000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6722000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
2209000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
2456000 usd
us-gaap Gross Profit
GrossProfit
6797000 usd
us-gaap Gross Profit
GrossProfit
6710000 usd
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1760000 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2052000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5424000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6489000 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
777000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1159000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4129000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4607000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
12835000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
13432000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3029000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3712000 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2311000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2176000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6574000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8172000 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
4848000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
5387000 usd
us-gaap Operating Expenses
OperatingExpenses
15027000 usd
us-gaap Operating Expenses
OperatingExpenses
18373000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2639000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2931000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-8230000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-11663000 usd
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
79000 usd
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
64000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
210000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
236000 usd
CY2024Q3 ekso Gain Loss On Warrant Modification
GainLossOnWarrantModification
0 usd
CY2023Q3 ekso Gain Loss On Warrant Modification
GainLossOnWarrantModification
0 usd
ekso Gain Loss On Warrant Modification
GainLossOnWarrantModification
-109000 usd
ekso Gain Loss On Warrant Modification
GainLossOnWarrantModification
0 usd
CY2024Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
14000 usd
CY2023Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
60000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
440000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
186000 usd
CY2024Q3 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
634000 usd
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-433000 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
194000 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-223000 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-48000 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
567000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-434000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
313000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-321000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-2072000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-3365000 usd
us-gaap Net Income Loss
NetIncomeLoss
-7917000 usd
us-gaap Net Income Loss
NetIncomeLoss
-11984000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-527000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
374000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-144000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
170000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2599000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2991000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8061000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11814000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.1
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.24
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.42
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.88
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20310000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14073000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18657000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13672000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
12606000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-3429000 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3970000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
237000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
376000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
291000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
14051000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-2416000 usd
CY2024Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
47000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
284000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
92000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
12059000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-2072000 usd
CY2024Q3 ekso Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
0 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
406000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-527000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
14870000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
25442000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-4389000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
424000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-194000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
21283000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-4230000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
249000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
514000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-10000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
17807000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-3365000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
441000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
374000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
15257000 usd
us-gaap Net Income Loss
NetIncomeLoss
-7917000 usd
us-gaap Net Income Loss
NetIncomeLoss
-11984000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1210000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1266000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
73000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
25000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
440000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
186000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1066000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1379000 usd
ekso Gain Loss On Warrant Modification
GainLossOnWarrantModification
-109000 usd
ekso Gain Loss On Warrant Modification
GainLossOnWarrantModification
-0 usd
ekso Common Stock Contribution
CommonStockContribution
177000 usd
ekso Common Stock Contribution
CommonStockContribution
304000 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
194000 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-223000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1427000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1348000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
80000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
162000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-63000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
370000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-41000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-647000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-852000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-522000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-160000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
1552000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8413000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10470000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
114000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-16000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-114000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
938000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
-0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
9021000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8083000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-4000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-346000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-10588000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8638000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
20525000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8292000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9937000 usd
us-gaap Interest Paid Net
InterestPaidNet
142000 usd
us-gaap Interest Paid Net
InterestPaidNet
145000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
9000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
33000 usd
ekso Transfer Of Property And Equipment From Inventory
TransferOfPropertyAndEquipmentFromInventory
105000 usd
ekso Transfer Of Property And Equipment From Inventory
TransferOfPropertyAndEquipmentFromInventory
-146000 usd
ekso Operating Leases Liability Right Of Use Asset Initial Recognition
OperatingLeasesLiabilityRightOfUseAssetInitialRecognition
180000 usd
ekso Operating Leases Liability Right Of Use Asset Initial Recognition
OperatingLeasesLiabilityRightOfUseAssetInitialRecognition
0 usd
us-gaap Stock Issued1
StockIssued1
1000 usd
us-gaap Stock Issued1
StockIssued1
0 usd
ekso Operating Leases Liability Right Of Use Asset Modification
OperatingLeasesLiabilityRightOfUseAssetModification
0 usd
ekso Operating Leases Liability Right Of Use Asset Modification
OperatingLeasesLiabilityRightOfUseAssetModification
-10000 usd
ekso Shares Issued Capital Contribution
SharesIssuedCapitalContribution
237000 usd
ekso Shares Issued Capital Contribution
SharesIssuedCapitalContribution
249000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-247062000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8413000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8292000 usd
CY2024Q3 ekso Debt Covenant Covenant Compliance Unrestricted Cash
DebtCovenantCovenantComplianceUnrestrictedCash
2000000 usd
ekso Unrestricted Cash
UnrestrictedCash
6292000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Use of Estimates</i></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet, and the reported amounts of revenues and expenses during the reporting period. For the Company, these estimates include, but are <em style="font: inherit;">not</em> limited to, intangible and tangible assets acquired and liabilities assumed in business combinations, revenue recognition, deferred revenue, the valuation of warrants and employee equity awards, future warranty costs, accounting for leases, useful lives assigned to long-lived assets, valuation of inventory, realizability of deferred tax assets, and contingencies. Actual results could differ from those estimates.</p> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"> </p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Concentration of Credit Risk and Other Risks and Uncertainties</i></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and accounts receivable.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company's cash balances held in domestic banks are deposited into accounts at various institutions with each balance under the <em style="font: inherit;">$250</em> Federal Deposit Insurance Corporation ("FDIC") insurance limit. The Company has significant cash balances at foreign financial institutions which regularly exceed the applicable country cash deposit insurance limits of approximately <em style="font: inherit;">$100</em> at each of the Company's <em style="font: inherit;">two</em> foreign banks. Any foreign exchange loss incurred or a lack of access to such funds could have a significant adverse impact on the Company's financial condition, results of operations, and cash flows.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company extends credit to customers in the normal course of business. Concentrations of credit risk with respect to accounts receivable exist to the full extent of amounts presented in the condensed consolidated financial statements. The Company does <em style="font: inherit;">not</em> require collateral from its customers to secure accounts receivable. Accounts receivable are derived from the sale of products shipped and services performed for customers primarily located in the U.S., Europe, Asia, and Australia. Invoices are aged based on contractual terms with the customer. The Company reviews accounts receivable for collectability and provides an allowance for potential credit losses. The allowance for potential credit losses on trade receivables reflects the Company’s best estimate of probable losses inherent in the accounts receivable balance based on known troubled accounts, historical experience, and other currently available evidence. Payment terms and conditions vary by contract type, although terms generally include a requirement of payment within <em style="font: inherit;">30</em> to <em style="font: inherit;">90</em> days. The Company has <em style="font: inherit;">not</em> experienced material losses related to accounts receivable as of <em style="font: inherit;"> September 30, 2024</em> and <em style="font: inherit;"> December 31, 2023</em>.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Many of the sales contracts with customers outside of the U.S. are settled in a foreign currency other than the U.S. dollar. The Company does <em style="font: inherit;">not</em> enter into any foreign currency hedging agreements and is susceptible to gains and losses from foreign currency fluctuations. To date, the Company has <em style="font: inherit;">not</em> experienced significant gains or losses upon collecting receivables denominated in a foreign currency.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company had<span style="background-color:#ffffff;"><span style="-sec-ix-hidden:c118478028">two</span></span> customers with an accounts receivable balance totaling <em style="font: inherit;">10%</em> or more of the Company’s total accounts receivable as of <em style="font: inherit;"> September 30, 2024</em><span style="background-color:#ffffff;"> (14% and 13%), as</span> compared with <span style="-sec-ix-hidden:c118478032">no</span> customers as of <em style="font: inherit;"> December 31, 2023</em>.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">During the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> September 30, 2024</em>, the Company had <span style="-sec-ix-hidden:c118478034">one</span> customer with sales of <em style="font: inherit;">10%</em> or more of the Company’s total reven<span style="background-color:#ffffff;">ue (26%), as</span> compared with <span style="-sec-ix-hidden:c118478037">three</span> customers in the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> September 30, 2023</em> (18%, 11% and 11%).</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">During the <em style="font: inherit;">nine</em> months ended <em style="font: inherit;"> September 30, 2024</em>, the Company had one customer with sales of <em style="font: inherit;">10%</em> or more of the Company’s total reve<span style="background-color:#ffffff;">nue (15%), a</span>s compared with <span style="-sec-ix-hidden:c118478046">two</span> customers in the <em style="font: inherit;">nine</em> months ended <em style="font: inherit;"> September 30, 2023</em> (17% and 10%).</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p>
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-144000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
170000 usd
CY2024Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
3917000 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
4298000 usd
CY2024Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
301000 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
290000 usd
CY2024Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
813000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
462000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
5031000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
5050000 usd
CY2024Q3 ekso Contract With Customer Liability Extended Maintenance And Support
ContractWithCustomerLiabilityExtendedMaintenanceAndSupport
3850000 usd
CY2023Q4 ekso Contract With Customer Liability Extended Maintenance And Support
ContractWithCustomerLiabilityExtendedMaintenanceAndSupport
3993000 usd
CY2024Q3 ekso Contract With Customer Liability Devices And Advances
ContractWithCustomerLiabilityDevicesAndAdvances
160000 usd
CY2023Q4 ekso Contract With Customer Liability Devices And Advances
ContractWithCustomerLiabilityDevicesAndAdvances
169000 usd
CY2024Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
4010000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
4162000 usd
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2039000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1993000 usd
CY2024Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1971000 usd
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2169000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
4162000 usd
ekso Contract With Customer Liability Deferral Of Revenue
ContractWithCustomerLiabilityDeferralOfRevenue
2168000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-2320000 usd
CY2024Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
4010000 usd
CY2024Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
703000 usd
CY2024Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1559000 usd
CY2024Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1748000 usd
CY2024Q3 ekso Contract With Customer Liability Noncancellable Backlog
ContractWithCustomerLiabilityNoncancellableBacklog
3417000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4129000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4607000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
12835000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
13432000 usd
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1414000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2058000 usd
CY2024Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
443000 usd
CY2023Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
461000 usd
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
118000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
145000 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1975000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2664000 usd
CY2024Q3 us-gaap Goodwill
Goodwill
431000 usd
CY2024Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
5220000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
558000 usd
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4662000 usd
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
5220000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
328000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4892000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
82000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
345000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
345000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
345000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
345000 usd
CY2024Q3 ekso Finitelived Intangible Asset Expected Amortization After Year Four
FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour
890000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2352000 usd
CY2024Q3 ekso Acquired Finitelived Intangible Asset Amortization
AcquiredFinitelivedIntangibleAssetAmortization
77000 usd
CY2023Q3 ekso Acquired Finitelived Intangible Asset Amortization
AcquiredFinitelivedIntangibleAssetAmortization
82000 usd
ekso Acquired Finitelived Intangible Asset Amortization
AcquiredFinitelivedIntangibleAssetAmortization
230000 usd
ekso Acquired Finitelived Intangible Asset Amortization
AcquiredFinitelivedIntangibleAssetAmortization
245000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
127000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
484000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
431000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
41000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1083000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
93000 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
990000 usd
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y1M24D
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.083 pure
CY2024Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
161000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
432000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
417000 usd
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
141429000
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21998000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14848000
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1240000
ekso Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
14900000
CY2024Q3 ekso Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
-193000
ekso Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
-335000
CY2024Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
15612000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
0 usd
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
406000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
441000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1066000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1379000 usd
us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.50 pure
ekso Common Stock Contribution
CommonStockContribution
177000 usd
ekso Common Stock Contribution
CommonStockContribution
304000 usd
CY2024Q3 us-gaap Purchase Obligation
PurchaseObligation
1511000 usd
CY2023Q4 us-gaap Purchase Obligation
PurchaseObligation
2783000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1083000 usd
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2072000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3365000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7917000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11984000 usd
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20310000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14073000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18657000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13672000
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.1
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.24
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.88
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14266000
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2968000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14266000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2968000
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4129000 usd
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1920000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
2209000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4607000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2151000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
2456000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
12835000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6038000 usd
us-gaap Gross Profit
GrossProfit
6797000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
13432000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6722000 usd
us-gaap Gross Profit
GrossProfit
6710000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4129000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4607000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
12835000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
13432000 usd

Files In Submission

Name View Source Status
ekso-20240930_cal.xml Edgar Link unprocessable
ekso20240930_10q_htm.xml Edgar Link completed
0001437749-24-032291-index-headers.html Edgar Link pending
0001437749-24-032291-index.html Edgar Link pending
0001437749-24-032291.txt Edgar Link pending
0001437749-24-032291-xbrl.zip Edgar Link pending
ekso-20240930.xsd Edgar Link pending
ekso20240930_10q.htm Edgar Link pending
ex_719122.htm Edgar Link pending
ex_719123.htm Edgar Link pending
ex_719124.htm Edgar Link pending
ex_719125.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
ekso-20240930_def.xml Edgar Link unprocessable
ekso-20240930_pre.xml Edgar Link unprocessable
ekso-20240930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending